Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2013
05/15/2013CN101627034B Amino- pyridine derivatives as s1p1 /edg1 receptor agonists
05/15/2013CN101574346B Method of using reserpine to construct animal model with continuous low level of serum melatonin
05/15/2013CN101516386B Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders
05/15/2013CN101495486B Camptothecin derivatives with antitumor activity
05/15/2013CN101486713B Furo[2,3-h] chromene compound and use for preventing platelet aggregation
05/15/2013CN101467971B Dispersible tablet containing letrozole
05/15/2013CN101466407B Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
05/15/2013CN101461801B Oxaliplatin medicament composition and preparation method thereof
05/15/2013CN101392229B Engineering strain for directly producing gernebcin and use thereof
05/15/2013CN101392015B Triterpene saponin in camellia seeds, preparation method and medical use thereof
05/15/2013CN101331138B One pot synthesis of tetrazole derivatives of sirolimus
05/15/2013CN101215276B N,N'-substituted phenylpropylamino acid phenylpropylaminoalcohols esters derivatives and preparation method thereof
05/15/2013CN101171927B Choline-silicic acid complex with osmolytes and divalent trace elements
05/15/2013CN101019853B Composition containing dihomo-gamma-linolenic acid (DGLA) as the active ingredient
05/15/2013CA2795586A1 Methods and compositions for treatment, modification and management of bone cancer pain
05/14/2013US8440842 Antimicrobial compounds, their synthesis and their use for treatment of mammalian infections
05/14/2013US8440839 Dinitropyrazole derivatives, their preparation, and energetic compositions comprising them
05/14/2013US8440837 2-substituted-ethynylthiazole derivatives and uses of same
05/14/2013US8440834 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors
05/14/2013US8440833 Human papilloma virus inhibitors and pharmaceutical compositions containing same
05/14/2013US8440832 Heterocyclic modulators of cannabinoid receptors
05/14/2013US8440830 Tetrahydro-fused pyridines as histone deacetylase inhibitors
05/14/2013US8440827 Photolabile caged transition metal complexes and methods of using the same
05/14/2013US8440819 Therapeutic substituted beta-lactams
05/14/2013US8440814 Derivatives of cyclodextrins, process for their preparation and their use in particular for solubilizing pharmacologically active substances
05/14/2013US8440813 Antiviral nucleoside analogs
05/14/2013US8440725 Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria
05/14/2013US8440724 Inhibiting neurotransmitter reuptake
05/14/2013US8440722 Methods for concomitant administration of colchicine and a second active agent
05/14/2013US8440721 Methods for concomitant administration of colchicine and a second active agent
05/14/2013US8440720 Methods of use of antiviral compounds
05/14/2013US8440719 Preservatives based on carboxylic anhydrides
05/14/2013US8440718 Modulation of inflammation related to columnar epithelia
05/14/2013US8440716 Deacetylase inhibitors and uses thereof
05/14/2013US8440715 Treatment of sleep-wake disorders
05/14/2013US8440713 [1]benzothieno[3,2-B][1]benzothiophene compound and method for producing the same, and organic electronic device using the same
05/14/2013US8440711 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them
05/14/2013US8440710 HSL inhibitors useful in the treatment of diabetes
05/14/2013US8440709 Polymorphs and amorphous forms of 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile
05/14/2013US8440708 Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists
05/14/2013US8440707 Antagonists of lysophosphatidic acid receptors
05/14/2013US8440706 Inhibitors of serine proteases
05/14/2013US8440705 Compounds, compositions and methods of inhibiting alpha-synuclein toxicity
05/14/2013US8440704 enhancing physical performance or immune system recovery from intense physical exercise by administering quercetin, vitamin B3, and vitamin C
05/14/2013US8440703 Methods of using sustained release aminopyridine compositions
05/14/2013US8440702 1,3-oxazolidin -2-one derivatives useful as CETP inhibitors
05/14/2013US8440701 Trisubstituted 1,2,4 triazoles
05/14/2013US8440700 Substituted aryloxazoles and their use
05/14/2013US8440698 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
05/14/2013US8440697 Treatment of heart failure
05/14/2013US8440696 Method of using diketopiperazines and composition containing them
05/14/2013US8440695 Use of chloroquine to treat metabolic syndrome
05/14/2013US8440694 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor
05/14/2013US8440693 Substituted isoquinolinones and quinazolinones
05/14/2013US8440692 Hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents
05/14/2013US8440691 Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
05/14/2013US8440690 Quinuclidine carbonate salts and medicinal composition thereof
05/14/2013US8440689 Fused heteroaromatic pyrrolidinones
05/14/2013US8440687 Oligomer-opioid agonist conjugates
05/14/2013US8440686 Nalmefene prodrugs
05/14/2013US8440685 Method for treatment of neurologic dysfunction
05/14/2013US8440684 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (FPRL-1) receptor modulators
05/14/2013US8440683 Pharmaceutical preparation for treating demyelinating diseases of the nervous system; preparation promoting restoration of the myelin sheath of nerve fibers; and a method for treating demyelinating diseases of the nervous system
05/14/2013US8440682 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors
05/14/2013US8440681 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
05/14/2013US8440680 2,6-diphenyl-4,8-diazoadamantan-1-one and derivatives thereof, process of manufacture and use for the formulation of solutions with sterilizing and disinfectant effect
05/14/2013US8440679 Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors
05/14/2013US8440678 Pharmaceutical composition
05/14/2013US8440677 Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
05/14/2013US8440676 Sweetener compositions and methods of making them
05/14/2013US8440673 Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
05/14/2013US8440672 Diphenyl substituted alkanes
05/14/2013US8440671 Compositions comprising a phoshodiesterase-5 inhibitor and their use in methods of treatment
05/14/2013US8440670 Pyridopyrazindione derivative and its use as an antiulcer drug
05/14/2013US8440669 Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-IV, and other antidiabetic or antiobesity agents as active ingredients
05/14/2013US8440668 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes
05/14/2013US8440667 Imidazopyrazine Syk inhibitors
05/14/2013US8440666 Pyridazinone compounds and P2X7 receptor inhibitors
05/14/2013US8440665 Apoptosis signal-regulating kinase inhibitors
05/14/2013US8440664 Heteroaryls and uses thereof
05/14/2013US8440663 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of use
05/14/2013US8440662 Substituted quinazoline and pyrido-pyrimidine derivatives
05/14/2013US8440661 Methods of modulating inflammatory cell recruitment and gene expression using haloaryl substituted aminopurines
05/14/2013US8440660 Method for treating a disease related to the glucocorticoid receptor
05/14/2013US8440658 Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
05/14/2013US8440657 Substituted piperidines
05/14/2013US8440656 Methods of treating pulmonary diseases and disorders by modulating calcium/calmodulin dependent protein kinase II activity
05/14/2013US8440655 Combination therapy for the treatment of diabetes
05/14/2013US8440654 Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
05/14/2013US8440653 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
05/14/2013US8440652 MST1 kinase inhibitors and methods of their use
05/14/2013US8440651 Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use
05/14/2013US8440650 Methods of treating hypertriglyceridemia
05/14/2013US8440649 Phenanthroindolizidine analogues
05/14/2013US8440648 Methods and compositions for treatment of intraepithelial neoplasia
05/14/2013US8440647 2α-methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses
05/14/2013US8440646 Substituted tetracycline compounds for treatment of Bacillus anthracis infections
05/14/2013US8440644 Compounds as receptor modulators with therapeutic utility
05/14/2013US8440643 Inhibitors of beta-lactamase
05/14/2013US8440642 Boron-containing small molecules
1 ... 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 ... 7860